{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T22:47:09Z","timestamp":1774997229663,"version":"3.50.1"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,1,18]],"date-time":"2022-01-18T00:00:00Z","timestamp":1642464000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,1,18]],"date-time":"2022-01-18T00:00:00Z","timestamp":1642464000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Health Clinical Research Project of Shanghai Municipal Health Commission","award":["202040328"],"award-info":[{"award-number":["202040328"]}]},{"name":"Peripheral Arteriovenous Malformations Biological Sample Bank Construction Project of Shanghai Ninth People\u2019s hospital","award":["YBKB202104"],"award-info":[{"award-number":["YBKB202104"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hereditas"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Maffucci syndrome (MS, OMIM 166000) is an extremely unusual, nonhereditary, multisystemic disorder that is characterized with multiple enchondromas and vascular lesions, most of which are spindle cell hemangiomas. Complications of MS, such as bone deformities and dysfunction caused by enchondromas, usually increase during childhood and adolescence. Malignant transformation of enchondromas and other malignancies are the most severe complications. MS is caused by somatic mosaic IDH1\/2 mutations, 65% of which are the IDH1 p.Arg132Cys variant. Due to its rarity, there is no international consensus for the most appropriate treatment option of MS.<\/jats:p><jats:p>Here, we report a case of a female patient presenting with multiple enchondromas and spindle cell hemangiomas (SCHs) on bilateral hand and feet diagnosed as MS. A detailed clinical, pathological and genetic diagnosis of MS was rendered. Integrative Genomics Viewer (IGV) visualization of next-generation sequencing (NGS) data revealed the consistent detection of the low-frequency somatic IDH1 p.Arg132Cys mutation between SCH tissue and cystic blood-derived cfDNA. This is the first successful molecular diagnosis of MS complicated with SCH utilizing minimally invasive cfDNA techniques. We suggest that cfDNA sequencing could potentially be used as an alternative, reliable and sensitive method to identify molecular information for genetic diagnosis and for future targeted therapies of MS.<\/jats:p>","DOI":"10.1186\/s41065-022-00223-2","type":"journal-article","created":{"date-parts":[[2022,1,18]],"date-time":"2022-01-18T09:22:59Z","timestamp":1642497779000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Cell-free DNA from plasma as a promising alternative for detection of gene mutations in patients with Maffucci syndrome"],"prefix":"10.1186","volume":"159","author":[{"given":"Yi","family":"Sun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xindong","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yamin","family":"Rao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenfeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deming","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xitao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lianzhou","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingzhe","family":"Wen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6025-0170","authenticated-orcid":false,"given":"Ren","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lixin","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,1,18]]},"reference":[{"issue":"1","key":"223_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13104-016-1913-x","volume":"9","author":"O Prokopchuk","year":"2016","unstructured":"Prokopchuk O, Andres S, Becker K, Holzapfel K, Hartmann D, Friess H. Maffucci syndrome and neoplasms: a case report and review of the literature. BMC research notes. 2016;9(1):1\u20137.","journal-title":"BMC research notes"},{"issue":"12","key":"223_CR2","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1634\/theoncologist.2011-0200","volume":"16","author":"SH Verdegaal","year":"2011","unstructured":"Verdegaal SH, Bov\u00e9e JV, Pansuriya TC, et al. Incidence, predictive factors, and prognosis of chondrosarcoma in patients with Ollier disease and Maffucci syndrome: an international multicenter study of 161 patients. Oncologist. 2011;16(12):1771.","journal-title":"Oncologist"},{"issue":"9","key":"223_CR3","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1097\/00000478-199509000-00006","volume":"19","author":"J Fanburg","year":"1995","unstructured":"Fanburg J, Meis-Kindblom J, Rosenberg A. Multiple enchondromas associated with spindle-cell hemangioendotheliomas. An overlooked variant of Maffucci's syndrome. Am J Surg Pathol. 1995;19(9):1029\u201338.","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"223_CR4","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1002\/ajmg.a.61530","volume":"182","author":"JM El Abiad","year":"2020","unstructured":"El Abiad JM, Robbins SM, Cohen B, et al. Natural history of Ollier disease and Maffucci syndrome: patient survey and review of clinical literature. Am J Med Genet A. 2020;182(5):1093\u2013103.","journal-title":"Am J Med Genet A"},{"issue":"3","key":"223_CR5","first-page":"375","volume":"35","author":"D Casal","year":"2010","unstructured":"Casal D, Mavioso C, Mendes MM, Mouzinho MM. Hand involvement in Ollier disease and Maffucci syndrome: a case series. Acta reumatologica portuguesa. 2010;35(3):375\u20138.","journal-title":"Acta reumatologica portuguesa"},{"issue":"4","key":"223_CR6","first-page":"381","volume":"11","author":"T Davidson","year":"1985","unstructured":"Davidson T, Kissin M, Bradish C, Westbury G. Angiosarcoma arising in a patient with Maffucci syndrome. Euro j surg oncol. 1985;11(4):381\u20134.","journal-title":"Euro j surg oncol"},{"issue":"6","key":"223_CR7","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1016\/0002-9343(76)90421-6","volume":"61","author":"AM Schnall","year":"1976","unstructured":"Schnall AM, Genuth SM. Multiple endocrine adenomas in a patient with the Maffucci syndrome. Am J Med. 1976;61(6):952\u20136.","journal-title":"Am J Med"},{"issue":"6","key":"223_CR8","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.3171\/2015.4.JNS15191","volume":"124","author":"S Hao","year":"2016","unstructured":"Hao S, Hong CS, Feng J, et al. Somatic IDH1 mutation in a pituitary adenoma of a patient with Maffucci syndrome. J Neurosurg. 2016;124(6):1562\u20137.","journal-title":"J Neurosurg"},{"issue":"1","key":"223_CR9","doi-asserted-by":"publisher","first-page":"61","DOI":"10.2165\/00128071-200809010-00008","volume":"9","author":"M Abdelmalek","year":"2008","unstructured":"Abdelmalek M, Stanko C. Recurrent chondrosarcoma of the right skull base in a patient with Maffucci syndrome. Am J Clin Dermatol. 2008;9(1):61\u20135.","journal-title":"Am J Clin Dermatol"},{"issue":"3","key":"223_CR10","doi-asserted-by":"publisher","first-page":"e12919","DOI":"10.1111\/dth.12919","volume":"32","author":"R Lekwuttikarn","year":"2019","unstructured":"Lekwuttikarn R, Chang J, Teng JM. Successful treatment of spindle cell hemangiomas in a patient with Maffucci syndrome and review of literatures. Dermatol Ther. 2019;32(3):e12919.","journal-title":"Dermatol Ther"},{"issue":"12","key":"223_CR11","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1038\/ng.994","volume":"43","author":"MF Amary","year":"2011","unstructured":"Amary MF, Damato S, Halai D, et al. Ollier disease and Maffucci syndrome are caused by somatic mosaic mutations of IDH1 and IDH2. Nat Genet. 2011;43(12):1262\u20135.","journal-title":"Nat Genet"},{"issue":"12","key":"223_CR12","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1038\/ng.1004","volume":"43","author":"TC Pansuriya","year":"2011","unstructured":"Pansuriya TC, Van Eijk R, d'Adamo P, et al. Somatic mosaic IDH1 and IDH2 mutations are associated with enchondroma and spindle cell hemangioma in Ollier disease and Maffucci syndrome. Nat Genet. 2011;43(12):1256\u201361.","journal-title":"Nat Genet"},{"issue":"1","key":"223_CR13","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/s41436-020-00943-8","volume":"23","author":"K Zenner","year":"2021","unstructured":"Zenner K, Jensen DM, Cook TT, et al. Cell-free DNA as a diagnostic analyte for molecular diagnosis of vascular malformations. Genetics in Medicine. 2021;23(1):123\u201330.","journal-title":"Genetics in Medicine"},{"issue":"1","key":"223_CR14","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1177\/1708538120936421","volume":"29","author":"M Palmieri","year":"2021","unstructured":"Palmieri M, Pinto AM, di Blasio L, et al. A pilot study of next generation sequencing\u2013liquid biopsy on cell-free DNA as a novel non-invasive diagnostic tool for Klippel\u2013Trenaunay syndrome. Vascular. 2021;29(1):85\u201391.","journal-title":"Vascular."},{"key":"223_CR15","first-page":"176","volume":"1","author":"M Palmieri","year":"2020","unstructured":"Palmieri M, Curr\u00f2 A, Tommasi A, et al. Cell-free DNA next-generation sequencing liquid biopsy as a new revolutionary approach for arteriovenous malformation. JVS: vascular Science. 2020;1:176\u201380.","journal-title":"JVS: vascular Science"},{"issue":"3","key":"223_CR16","first-page":"740","volume":"9","author":"M Palmieri","year":"2021","unstructured":"Palmieri M, Di Sarno L, Tommasi A, et al. MET somatic activating mutations are responsible for lymphovenous malformation and can be identified using cell-free DNA next generation sequencing liquid biopsy. J Vasc Surg. 2021;9(3):740\u20134.","journal-title":"J Vasc Surg"},{"key":"223_CR17","doi-asserted-by":"crossref","unstructured":"Blei FISSVA. Classification of Vascular Anomalies. 2017.","DOI":"10.1007\/978-3-662-46709-1_8"},{"issue":"4","key":"223_CR18","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1159\/000348327","volume":"4","author":"J Soblet","year":"2013","unstructured":"Soblet J, Limaye N, Uebelhoer M, Boon L, Vikkula M. Variable somatic TIE2 mutations in half of sporadic venous malformations. Mol syndromol. 2013;4(4):179\u201383.","journal-title":"Mol syndromol"},{"key":"223_CR19","first-page":"241","volume":"142","author":"P Mandel","year":"1948","unstructured":"Mandel P. Les acides nucleiques du plasma sanguin chez 1 homme. CR Seances Soc Biol Fil. 1948;142:241\u20133.","journal-title":"CR Seances Soc Biol Fil"},{"issue":"7","key":"223_CR20","doi-asserted-by":"publisher","first-page":"664","DOI":"10.18632\/oncotarget.567","volume":"3","author":"ES Kandel","year":"2012","unstructured":"Kandel ES. Mutations in circulating mitochondrial DNA: Cassandra of oral cancer? Oncotarget. 2012;3(7):664.","journal-title":"Oncotarget."},{"issue":"6","key":"223_CR21","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1038\/nrc3066","volume":"11","author":"H Schwarzenbach","year":"2011","unstructured":"Schwarzenbach H, Hoon DS, Pantel K. Cell-free nucleic acids as biomarkers in cancer patients. Nat Rev Cancer. 2011;11(6):426.","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"223_CR22","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1186\/s13023-019-1191-5","volume":"14","author":"M Ozeki","year":"2019","unstructured":"Ozeki M, Aoki Y, Nozawa A, et al. Detection of NRAS mutation in cell-free DNA biological fluids from patients with kaposiform lymphangiomatosis. Orphanet journal of rare diseases. 2019;14(1):215.","journal-title":"Orphanet journal of rare diseases"},{"key":"223_CR23","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1182\/blood-2018-99-110449","volume":"132","author":"EM Stein","year":"2018","unstructured":"Stein EM, DiNardo CD, Fathi AT, et al. Ivosidenib or enasidenib combined with induction and consolidation chemotherapy in patients with newly diagnosed AML with an IDH1 or IDH2 mutation is safe, effective, and leads to MRD-negative complete remissions. Blood. 2018;132:560.","journal-title":"Blood."},{"issue":"6","key":"223_CR24","first-page":"722","volume":"130","author":"EM Stein","year":"2017","unstructured":"Stein EM, DiNardo CD, Pollyea DA, et al. Enasidenib in mutant IDH2 relapsed or refractory acute myeloid leukemia blood. J Am Soc Hematol. 2017;130(6):722\u201331.","journal-title":"J Am Soc Hematol"}],"container-title":["Hereditas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41065-022-00223-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41065-022-00223-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41065-022-00223-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,23]],"date-time":"2023-01-23T10:43:37Z","timestamp":1674470617000},"score":1,"resource":{"primary":{"URL":"https:\/\/hereditasjournal.biomedcentral.com\/articles\/10.1186\/s41065-022-00223-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,18]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["223"],"URL":"https:\/\/doi.org\/10.1186\/s41065-022-00223-2","relation":{},"ISSN":["1601-5223"],"issn-type":[{"value":"1601-5223","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,18]]},"assertion":[{"value":"25 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The patient give written informed consent before participation.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The patient give written informed consent for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"No competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4"}}